Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 89

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

570	$NVLX Investors Confidently Back Nuvilex's	stocklegend	03/04/2014 1:10:23 PM
569	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	03/04/2014 11:54:50 AM
568	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	03/04/2014 11:14:13 AM
567	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	03/04/2014 10:18:26 AM
566	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/04/2014 9:37:35 AM
565	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/04/2014 9:36:33 AM
564	$NVLX Nuvilex Begins Making Moves at its	stocklegend	03/04/2014 9:32:24 AM
563	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	03/04/2014 9:15:41 AM
562	$NVLX According to the American cancer Society,	Tandrel	03/04/2014 8:50:42 AM
561	$NVLX Company info and share structure	Tandrel	03/04/2014 8:49:37 AM
560	$NVLX Cells encapsulated using our technology can	Tandrel	03/04/2014 8:48:33 AM
559	$NVLX you can read more about the fascinating	Tandrel	03/04/2014 8:47:46 AM
558	$NVLX has acquired worldwide exclusive rights to	Tandrel	03/04/2014 8:47:01 AM
557	$NVLX's live-cell encapsulation technology is a	Tandrel	03/04/2014 8:46:12 AM
556	$NVLX Investor Relations contact info: Marlin	Tandrel	03/04/2014 8:45:29 AM
555	$NVLX breakout candles called $0.15 PYCKtradr	PoemStone	03/03/2014 8:41:24 PM
554	$NVLX Investors Confidently Back Nuvilex's	stocklegend	03/03/2014 3:44:58 PM
553	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	03/03/2014 2:20:52 PM
552	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	03/03/2014 1:05:58 PM
551	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	03/03/2014 11:48:28 AM
550	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	03/03/2014 10:58:21 AM
549	Have been in this since .12. Truly believe in	HennypennyAZ	03/03/2014 9:57:08 AM
548	$NVLX Nuvilex Begins Making Moves at its	stocklegend	03/03/2014 9:55:48 AM
547	NVLX news:	stocklegend	03/03/2014 9:22:04 AM
546	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	03/03/2014 8:46:44 AM
545	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/28/2014 2:31:42 PM
544	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/28/2014 2:01:26 PM
543	$NVLX Diabetes Treatment Drives Big Increase	stocklegend	02/28/2014 12:47:46 PM
542	$NVLX After Pancreatic Cancer, Eli Lilly and	stocklegend	02/28/2014 12:10:13 PM
541	$NVLX Nuvilex and Eli Lilly Going Head to	stocklegend	02/28/2014 11:20:38 AM
540	$NVLX Nuvilex Appoints Dr. Mark Rabe, a	stocklegend	02/28/2014 10:30:22 AM
539	$NVLX Nuvilex Begins Making Moves at its	stocklegend	02/28/2014 10:13:27 AM
538	NVLX Stock Charts Last: -0.0423 Friday, February	chartguy89	02/28/2014 10:09:44 AM
537	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	02/28/2014 8:58:29 AM
536	$NVLX Nuvilex COO, Dr. Gerald Crabtree,	stocklegend	02/27/2014 3:25:05 PM
535	$NVLX Nuvilex COO Talks About Companys	stocklegend	02/27/2014 3:22:32 PM
534	$NVLX Nuvilex, Inc. Featured on Forbes:	stocklegend	02/27/2014 2:08:46 PM
533	$NVLX Nuvilex Listed in Forbes Article on	stocklegend	02/27/2014 1:26:09 PM
532	$NVLX - Nuvilex COO Talks Medical Marijuana in NY	stocklegend	02/27/2014 12:25:56 PM
531	$NVLX - Nuvilex Featured in Forbes and NY Post	stocklegend	02/27/2014 12:00:27 PM
530	$NVLX - Nuvilex Acquires Cancer Cell	stocklegend	02/27/2014 11:27:58 AM
529	$NVLX - Nuvilex Acquires Cancer Technology, Next	stocklegend	02/27/2014 10:50:53 AM
528	$NVLX - Nuvilex Restructures its Operations to	stocklegend	02/27/2014 10:18:56 AM
527	$NVLX - Nuvilex Restructures to Focus on	stocklegend	02/27/2014 9:54:20 AM
526	$NVLX - Nuvilex Contracts with Inno Biologics to	stocklegend	02/27/2014 9:22:29 AM
525	$NVLX - Nuvilex Enters Most Important Step of	stocklegend	02/27/2014 8:55:15 AM
524	Looking soo good right now!	anarmyofme	02/26/2014 8:50:54 PM
523	$NVLX Nuvilex's Acquisition of Diabetes	stocklegend	02/26/2014 3:08:56 PM
522	$NVLX Nuvilex Ahead of the Curve on	stocklegend	02/26/2014 1:51:29 PM
521	$NVLX Investors Confidently Back Nuvilex's	stocklegend	02/26/2014 12:28:54 PM

Newer

Older

Recent Articles

• Investor Alert: Match Group Faces Securities Investigation
• Investors Monitor Class Action Against Xerox Ahead of Deadline
• Investor Advocacy: Join the Class Action for AMMO, Inc.
• Unlocking Rare Spirits: Cask Cartel's Cyber Monday Savings
• Investors Get Involved in Edwards Lifesciences Class Action
• Celsius Holdings Faces Class Action Lawsuit Over Misconduct
• Investors Urged to Act as Flux Power Faces Legal Scrutiny
• Evolv Technologies: Firm Investigates Investor Claims
• Investors Alert: Investigating Claims Against Acadia Healthcare
• Investigation into WM Technology by Faruqi & Faruqi, LLP
• Iris Energy Investors Alerted: Legal Investigation Underway
• Faruqi & Faruqi Investigates iLearningEngines Investor Claims
• Investors Take Note: Faruqi & Faruqi Looks Into Xiao-I Claims
• Investigation of Lilium N.V. by Faruqi & Faruqi, LLP
• Unmissable Cyber Monday Deals on Monport Laser Machines
• Elanco Animal Health Takes Legal Action Over Misleading Claims
• Midnight Hub NFT Investors: Join the Class Action for Justice
• Zeta Global Holdings Faces Class Action Lawsuit: Key Details
• AB Pieno žvaigzdes Reports Growth in Nine-Month Sales for 2024
• Celebrate the Holidays with Capriotti's 25 Days of Deals
• Positive Growth Indicators in PRFoods' Latest Interim Report
• Wright Way Enterprises Secures Major IRS Cybersecurity Contract
• Amber DWM and iClick Interactive Merge for Enhanced Growth
• Banco Comercial Português Reports Nine-Month Financial Results
• iLearningEngines, Inc. Investors: Important Legal Update Ahead
• ADGM's Asset Management Remarkably Thrives in Recent Quarter
• Explore Your Options in the Iris Energy Limited Securities Case
• BioTalent Canada Triumphs as Leader in Inclusion and Diversity
• Maximizing Online Presence with Free Website Audits
• Exploring Cultural Exchange Through 'Liangzhu' Documentary
• EDF Secures €6 Billion Credit Facility to Boost ESG Commitments
• Journey Through China's Ethnic Treasures: A Cultural Odyssey
• Transforming Waste into Sustainable Energy: Innovations Ahead
• Investors Urged to Join Class Action Against Chipotle
• Vantage Drilling Secures $50 Million in Senior Secured Notes
• Primega Group Holdings Resolves Nasdaq Compliance Issues
• Exploring Culinary Delights at the China Supply Chain Show
• High Arctic Overseas Reports Q3 2024 Financial Highlights
• Grab Unmissable Offers Before Monport's Black Friday Ends
• Canadian Spirit Resources Highlights First Quarter Financials
• Innovation at the Expo: Where Sci-Fi Meets Reality
• Rakovina Therapeutics Reports Q3 Financial Progress and Innovations
• Innovative Transportation Concepts at the China Supply Chain Expo
• Exploring Hotpot Culture at the China International Supply Chain Expo
• CBC Group and Mubadala Form NeuroGen Pharma for Growth
• GVD Markets Launches Global Expansion with Unique Trading Solutions
• CBC Group and Mubadala Form NeuroGen Pharma in China Deal
• Hampton Financial Corporation Distributes Stock Options for Growth
• Tice Family Takes Stand for Journalist in Press Conference
• ProMortgage Expands Team With Four Experienced Professionals